Novel CDK12/13 inhibitor CTX-439 downregulates MCL1 via transcriptional mRNA read-through and synergistically acts with BCL-XL inhibitors for cancer therapy

CTX-439 - Chordia Therap

AZD4320 - AstraZeneca

https://www.abstractsonline.com/pp8/#!/20273/presentation/6500

Hiroko Yamakawa; Raghda Khatab; Yusuke Tarumoto; Mariko Takano; Seiichi Sugino; Shafiqul Islam; Shunsuke Ebara; Kosuke Kawaguchi; Masakazu Toi; Akio Mizutani; Midori Sugiyama; Misaki Yoshida; Daisuke Morishita; Kosuke Yusa

Mar 26, 2025